About Conference
Bladder cancer is a disease that requires lifelong surveillance and is one of the most costly cancers to treat. In recent years, several advances in the treatment of bladder cancer at all stages have been achieved. In response to the BCG shortage, alternative intravesical therapies have proven to show efficacy, and several other treatments currently in clinical trials also show promise.
Highlights
Recognize what alternate treatments are available for patients with nonmuscle invasive bladder cancer who cannot receive BCG, Describe the role of surgery for patients with nonmuscle invasive bladder cancer, Explain the role of radiation therapy for patients with bladder cancer, Explain the role of systemic neoadjuvant therapy for patients with bladder cancer
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer
2.
EVP Beats Cisplatin for Resectable MIBC
3.
For elderly, unfit patients, the all-oral AML regimen shows promise.
4.
Study sets benchmark for treatment of advanced cervical cancer
5.
For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.
1.
Case-Based Learning on Adaptive Management of Oligometastatic Disease Across Treatment Phases
2.
The Link Between Being Overweight and Cancer
3.
Uncovering the Mysteries of the RDW Blood Test
4.
Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease
5.
Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Common Cancer Myths Debunked
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
Recommended News For You
1.
ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology
2.
Belgian Algorithm Reshapes Endometrial Cancer Care
3.
Cancer screening rates down among American adults
4.
For older LBCL patients, Axi-Cel exhibits durable responses and extends overall survival.
5.
Talc Powder Not Linked to Lung Cancer in Women
Conferences That Might Interest You
Recommended Articles For You
1.
Progressive Techniques in Oncology in Daily Practice
2.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
3.
Virtual Oncology Follow-Up: Current Practices, Evidence, and Clinical Implications
4.
Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies
5.
Novel Antibody Conjugates in Cancer: Mechanisms, Clinical Evidence, and Therapeutic Implications
Boost Your Knowledge With These Quizzes
1.
Quiz Of Principles Of Pediatric Anesthesia
2.
Quiz on Cold Agglutinin Disease Decoded: Pathophysiology and Cutting-Edge Therapies
3.
Quiz on Gene Therapy for Hemophilia Management
4.
Quiz on Congenital Adrenal Hyperplasia: Are You Up-to-Date on Treatment and Outcomes?
5.
Quiz on Latest Advancements in Antihypertensive Therapy
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge